{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:54:13Z","timestamp":1784951653136,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.psychres.2014.03.045","type":"journal-article","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T16:17:42Z","timestamp":1396714662000},"page":"143-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Blood\u2013cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment"],"prefix":"10.1016","volume":"217","author":[{"given":"Henrik","family":"Zetterberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Reds\u00e4ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Sellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette GM","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.03.045_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.psychres.2014.03.045_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1192\/bjp.141.3.273","article-title":"Impairment of the blood\u2013brain barrier as an aetiological factor in paranoid psychosis","volume":"141","author":"Axelsson","year":"1982","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"key":"10.1016\/j.psychres.2014.03.045_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00380949","article-title":"Blood\u2013cerebrospinal fluid barrier in schizophrenic patients","volume":"236","author":"Bauer","year":"1987","journal-title":"European Archives of Psychiatry and Neurological Sciences"},{"key":"10.1016\/j.psychres.2014.03.045_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0924-977X(96)00020-X","article-title":"Impairment of the blood\u2013CSF barrier in suicide attempters","volume":"6","author":"Bayard-Burfield","year":"1996","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.03.045_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood\u2013CSF barrier dysfunction","volume":"44","author":"Bechter","year":"2010","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2014.03.045_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"European Addiction Research"},{"key":"10.1016\/j.psychres.2014.03.045_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.psychres.2014.03.045_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood\u2013brain barrier disturbance in patients with Alzheimer\u05f3s disease is related to vascular factors","volume":"81","author":"Blennow","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.psychres.2014.03.045_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-510X(85)90189-3","article-title":"CSF in Alzheimer\u05f3s disease. Studies on blood-brain barrier function and intrathecal protein synthesis","volume":"70","author":"Elovaara","year":"1985","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.psychres.2014.03.045_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning. A modified scale","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psychres.2014.03.045_bib11","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1503\/jpn.120170","article-title":"Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder","volume":"38","author":"Jakobsson","year":"2013","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1016\/j.psychres.2014.03.045_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2012.231","article-title":"Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder","volume":"38","author":"Jakobsson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.03.045_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0006-3223(85)90002-2","article-title":"Abnormal cerebrospinal fluid protein indices in schizophrenia","volume":"20","author":"Kirch","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.03.045_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneurpsyc.1934.02250090060006","article-title":"Cerebrospinal fluid hydrodynamics IV. Clinical experimental studies","volume":"32","author":"Masserman","year":"1934","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1016\/j.psychres.2014.03.045_bib15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archneur.61.11.1721","article-title":"Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging","volume":"61","author":"Rapoport","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.psychres.2014.03.045_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2014a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.psychres.2014.03.045_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.psychres.2014.03.045_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0447.2009.01399.x","article-title":"A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD","volume":"120","author":"Ryden","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2014.03.045_bib19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","article-title":"Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"53","author":"Sachs","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.03.045_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.2042-7158.1992.tb03644.x","article-title":"Ageing influences haloperidol-induced changes in the permeability of the blood\u2013brain barrier in the rat","volume":"44","author":"Saija","year":"1992","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.psychres.2014.03.045_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"Suppl. 20","key":"10.1016\/j.psychres.2014.03.045_bib22","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.03.045_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1016\/j.psychres.2014.03.045_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(84)90748-0","article-title":"Choroid plexus blood flow: evidence for dopaminergic influence","volume":"290","author":"Townsend","year":"1984","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2014.03.045_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0404.1990.tb01562.x","article-title":"Blood brain barrier function in vascular dementia","volume":"81","author":"Wallin","year":"1990","journal-title":"Acta Neurologica Scandinavica"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114002728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114002728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T04:22:29Z","timestamp":1538713349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178114002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0165178114002728"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.03.045","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood\u2013cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}